• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
New and Improved: The Latest Research in Disease Screening

New and Improved: The Latest Research in Disease Screening

by Michael Schubert, PhD | Dec 17, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Top of the News-dtet

New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
How Do You Solve a Problem Like AI Regulation?

How Do You Solve a Problem Like AI Regulation?

by Oscelle Boye, MBiomed | Oct 28, 2024 | Essential, FDA-lca, Lab Industry Advisor

How the current FDA AI/ML device regulations may be impeding innovation in the clinical lab

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Proposal for LDTs Risks Serious Consequences

FDA Proposal for LDTs Risks Serious Consequences

by Gail Dutton | Oct 18, 2023 | Essential, FDA-lir, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter

Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New CMS Rule Unlikely to Speed Medicare Coverage of Breakthrough Devices

New CMS Rule Unlikely to Speed Medicare Coverage of Breakthrough Devices

by Rachel Muenz | Sep 6, 2023 | News, Open Content

The recently proposed TCET rule appears to be too stringent to significantly hasten the Medicare coverage process for device makers.

Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years

Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years

by Glenn S. Demby | May 4, 2023 | Essential, FDA-lir, Laboratory Industry Report

The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com